nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2A6—Prednisolone—psoriatic arthritis	0.203	0.235	CbGbCtD
Tranylcypromine—CYP2A6—Dexamethasone—psoriatic arthritis	0.12	0.138	CbGbCtD
Tranylcypromine—CYP2C19—Prednisone—psoriatic arthritis	0.0795	0.0917	CbGbCtD
Tranylcypromine—CYP2E1—Dexamethasone—psoriatic arthritis	0.0792	0.0914	CbGbCtD
Tranylcypromine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0634	0.0732	CbGbCtD
Tranylcypromine—CYP2C19—Dexamethasone—psoriatic arthritis	0.0496	0.0573	CbGbCtD
Tranylcypromine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0481	0.0555	CbGbCtD
Tranylcypromine—CYP2C9—Dexamethasone—psoriatic arthritis	0.0412	0.0476	CbGbCtD
Tranylcypromine—CYP3A4—Betamethasone—psoriatic arthritis	0.0412	0.0476	CbGbCtD
Tranylcypromine—CYP3A4—Prednisolone—psoriatic arthritis	0.0407	0.047	CbGbCtD
Tranylcypromine—CYP3A4—Prednisone—psoriatic arthritis	0.0384	0.0443	CbGbCtD
Tranylcypromine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0377	0.0435	CbGbCtD
Tranylcypromine—CYP3A4—Dexamethasone—psoriatic arthritis	0.024	0.0277	CbGbCtD
Tranylcypromine—Memory loss—Prednisone—psoriatic arthritis	0.00386	0.0289	CcSEcCtD
Tranylcypromine—Hypotensive—Dexamethasone—psoriatic arthritis	0.00357	0.0267	CcSEcCtD
Tranylcypromine—Hypotensive—Betamethasone—psoriatic arthritis	0.00357	0.0267	CcSEcCtD
Tranylcypromine—Agranulocytosis—Auranofin—psoriatic arthritis	0.00256	0.0191	CcSEcCtD
Tranylcypromine—Alopecia—Auranofin—psoriatic arthritis	0.00217	0.0163	CcSEcCtD
Tranylcypromine—Neck stiffness—Methotrexate—psoriatic arthritis	0.00199	0.0149	CcSEcCtD
Tranylcypromine—Anaemia—Auranofin—psoriatic arthritis	0.00198	0.0148	CcSEcCtD
Tranylcypromine—Mydriasis—Prednisolone—psoriatic arthritis	0.00196	0.0147	CcSEcCtD
Tranylcypromine—Leukopenia—Auranofin—psoriatic arthritis	0.00192	0.0144	CcSEcCtD
Tranylcypromine—Nuchal rigidity—Methotrexate—psoriatic arthritis	0.00183	0.0137	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00171	0.0128	CcSEcCtD
Tranylcypromine—Anorexia—Auranofin—psoriatic arthritis	0.00167	0.0125	CcSEcCtD
Tranylcypromine—Decreased appetite—Auranofin—psoriatic arthritis	0.00152	0.0114	CcSEcCtD
Tranylcypromine—Constipation—Auranofin—psoriatic arthritis	0.0015	0.0112	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00143	0.0107	CcSEcCtD
Tranylcypromine—Urticaria—Auranofin—psoriatic arthritis	0.00139	0.0104	CcSEcCtD
Tranylcypromine—Abdominal pain—Auranofin—psoriatic arthritis	0.00138	0.0103	CcSEcCtD
Tranylcypromine—Diarrhoea—Auranofin—psoriatic arthritis	0.0012	0.00895	CcSEcCtD
Tranylcypromine—Vomiting—Auranofin—psoriatic arthritis	0.00111	0.00832	CcSEcCtD
Tranylcypromine—Amnesia—Methylprednisolone—psoriatic arthritis	0.00111	0.00829	CcSEcCtD
Tranylcypromine—Rash—Auranofin—psoriatic arthritis	0.0011	0.00825	CcSEcCtD
Tranylcypromine—Dermatitis—Auranofin—psoriatic arthritis	0.0011	0.00824	CcSEcCtD
Tranylcypromine—Musculoskeletal stiffness—Methotrexate—psoriatic arthritis	0.00106	0.00792	CcSEcCtD
Tranylcypromine—Nausea—Auranofin—psoriatic arthritis	0.00104	0.00777	CcSEcCtD
Tranylcypromine—Amnesia—Prednisone—psoriatic arthritis	0.000877	0.00657	CcSEcCtD
Tranylcypromine—Bradycardia—Prednisolone—psoriatic arthritis	0.000799	0.00598	CcSEcCtD
Tranylcypromine—Haemoglobin—Prednisolone—psoriatic arthritis	0.000789	0.0059	CcSEcCtD
Tranylcypromine—Haemorrhage—Prednisolone—psoriatic arthritis	0.000785	0.00587	CcSEcCtD
Tranylcypromine—Sweating—Methylprednisolone—psoriatic arthritis	0.000769	0.00575	CcSEcCtD
Tranylcypromine—Bradycardia—Triamcinolone—psoriatic arthritis	0.000735	0.0055	CcSEcCtD
Tranylcypromine—Bradycardia—Methylprednisolone—psoriatic arthritis	0.000733	0.00549	CcSEcCtD
Tranylcypromine—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000725	0.00543	CcSEcCtD
Tranylcypromine—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.000724	0.00542	CcSEcCtD
Tranylcypromine—Haemorrhage—Triamcinolone—psoriatic arthritis	0.000722	0.0054	CcSEcCtD
Tranylcypromine—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.00072	0.00539	CcSEcCtD
Tranylcypromine—Bradycardia—Betamethasone—psoriatic arthritis	0.000667	0.00499	CcSEcCtD
Tranylcypromine—Bradycardia—Dexamethasone—psoriatic arthritis	0.000667	0.00499	CcSEcCtD
Tranylcypromine—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000658	0.00492	CcSEcCtD
Tranylcypromine—Haemoglobin—Betamethasone—psoriatic arthritis	0.000658	0.00492	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Prednisone—psoriatic arthritis	0.000656	0.00491	CcSEcCtD
Tranylcypromine—Haemorrhage—Betamethasone—psoriatic arthritis	0.000655	0.0049	CcSEcCtD
Tranylcypromine—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000655	0.0049	CcSEcCtD
Tranylcypromine—Ataxia—Methotrexate—psoriatic arthritis	0.000648	0.00485	CcSEcCtD
Tranylcypromine—Vision blurred—Prednisolone—psoriatic arthritis	0.000644	0.00482	CcSEcCtD
Tranylcypromine—Syncope—Prednisolone—psoriatic arthritis	0.000613	0.00458	CcSEcCtD
Tranylcypromine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.0006	0.00449	CcSEcCtD
Tranylcypromine—Hypertension—Prednisolone—psoriatic arthritis	0.00059	0.00441	CcSEcCtD
Tranylcypromine—Bradycardia—Prednisone—psoriatic arthritis	0.000581	0.00434	CcSEcCtD
Tranylcypromine—Alopecia—Dexamethasone—psoriatic arthritis	0.000579	0.00433	CcSEcCtD
Tranylcypromine—Alopecia—Betamethasone—psoriatic arthritis	0.000579	0.00433	CcSEcCtD
Tranylcypromine—Haemoglobin—Prednisone—psoriatic arthritis	0.000573	0.00429	CcSEcCtD
Tranylcypromine—Haemorrhage—Prednisone—psoriatic arthritis	0.00057	0.00427	CcSEcCtD
Tranylcypromine—Syncope—Triamcinolone—psoriatic arthritis	0.000563	0.00422	CcSEcCtD
Tranylcypromine—Syncope—Methylprednisolone—psoriatic arthritis	0.000562	0.00421	CcSEcCtD
Tranylcypromine—Oedema—Prednisolone—psoriatic arthritis	0.000558	0.00417	CcSEcCtD
Tranylcypromine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000552	0.00413	CcSEcCtD
Tranylcypromine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000551	0.00412	CcSEcCtD
Tranylcypromine—Shock—Prednisolone—psoriatic arthritis	0.000548	0.0041	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.000548	0.0041	CcSEcCtD
Tranylcypromine—Tachycardia—Prednisolone—psoriatic arthritis	0.000544	0.00407	CcSEcCtD
Tranylcypromine—Hypertension—Triamcinolone—psoriatic arthritis	0.000542	0.00406	CcSEcCtD
Tranylcypromine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000541	0.00405	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000539	0.00403	CcSEcCtD
Tranylcypromine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000532	0.00398	CcSEcCtD
Tranylcypromine—Drowsiness—Methotrexate—psoriatic arthritis	0.000531	0.00397	CcSEcCtD
Tranylcypromine—Flushing—Prednisone—psoriatic arthritis	0.000529	0.00396	CcSEcCtD
Tranylcypromine—Dry mouth—Triamcinolone—psoriatic arthritis	0.000523	0.00391	CcSEcCtD
Tranylcypromine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000516	0.00386	CcSEcCtD
Tranylcypromine—Oedema—Triamcinolone—psoriatic arthritis	0.000513	0.00384	CcSEcCtD
Tranylcypromine—Syncope—Betamethasone—psoriatic arthritis	0.000511	0.00383	CcSEcCtD
Tranylcypromine—Syncope—Dexamethasone—psoriatic arthritis	0.000511	0.00383	CcSEcCtD
Tranylcypromine—Sweating—Methotrexate—psoriatic arthritis	0.000509	0.00381	CcSEcCtD
Tranylcypromine—Shock—Triamcinolone—psoriatic arthritis	0.000504	0.00377	CcSEcCtD
Tranylcypromine—Insomnia—Prednisolone—psoriatic arthritis	0.000504	0.00377	CcSEcCtD
Tranylcypromine—Alopecia—Prednisone—psoriatic arthritis	0.000504	0.00377	CcSEcCtD
Tranylcypromine—Shock—Methylprednisolone—psoriatic arthritis	0.000503	0.00377	CcSEcCtD
Tranylcypromine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000501	0.00375	CcSEcCtD
Tranylcypromine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000501	0.00375	CcSEcCtD
Tranylcypromine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000501	0.00375	CcSEcCtD
Tranylcypromine—Tachycardia—Triamcinolone—psoriatic arthritis	0.0005	0.00374	CcSEcCtD
Tranylcypromine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000499	0.00374	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000496	0.00371	CcSEcCtD
Tranylcypromine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000495	0.00371	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000495	0.0037	CcSEcCtD
Tranylcypromine—Hypertension—Dexamethasone—psoriatic arthritis	0.000492	0.00368	CcSEcCtD
Tranylcypromine—Hypertension—Betamethasone—psoriatic arthritis	0.000492	0.00368	CcSEcCtD
Tranylcypromine—Anxiety—Dexamethasone—psoriatic arthritis	0.000484	0.00362	CcSEcCtD
Tranylcypromine—Anxiety—Betamethasone—psoriatic arthritis	0.000484	0.00362	CcSEcCtD
Tranylcypromine—Haemoglobin—Methotrexate—psoriatic arthritis	0.000479	0.00358	CcSEcCtD
Tranylcypromine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000478	0.00358	CcSEcCtD
Tranylcypromine—Pain—Prednisolone—psoriatic arthritis	0.000477	0.00357	CcSEcCtD
Tranylcypromine—Hepatitis—Methotrexate—psoriatic arthritis	0.000477	0.00357	CcSEcCtD
Tranylcypromine—Haemorrhage—Methotrexate—psoriatic arthritis	0.000477	0.00357	CcSEcCtD
Tranylcypromine—Vision blurred—Prednisone—psoriatic arthritis	0.000468	0.0035	CcSEcCtD
Tranylcypromine—Oedema—Dexamethasone—psoriatic arthritis	0.000465	0.00348	CcSEcCtD
Tranylcypromine—Oedema—Betamethasone—psoriatic arthritis	0.000465	0.00348	CcSEcCtD
Tranylcypromine—Insomnia—Triamcinolone—psoriatic arthritis	0.000464	0.00347	CcSEcCtD
Tranylcypromine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000463	0.00346	CcSEcCtD
Tranylcypromine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00046	0.00345	CcSEcCtD
Tranylcypromine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000459	0.00344	CcSEcCtD
Tranylcypromine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000459	0.00344	CcSEcCtD
Tranylcypromine—Anaemia—Prednisone—psoriatic arthritis	0.000459	0.00343	CcSEcCtD
Tranylcypromine—Shock—Betamethasone—psoriatic arthritis	0.000458	0.00342	CcSEcCtD
Tranylcypromine—Shock—Dexamethasone—psoriatic arthritis	0.000458	0.00342	CcSEcCtD
Tranylcypromine—Agitation—Prednisone—psoriatic arthritis	0.000456	0.00341	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000455	0.00341	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000455	0.00341	CcSEcCtD
Tranylcypromine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000454	0.0034	CcSEcCtD
Tranylcypromine—Tachycardia—Betamethasone—psoriatic arthritis	0.000454	0.0034	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00045	0.00337	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00045	0.00337	CcSEcCtD
Tranylcypromine—Syncope—Prednisone—psoriatic arthritis	0.000445	0.00333	CcSEcCtD
Tranylcypromine—Tinnitus—Methotrexate—psoriatic arthritis	0.000444	0.00333	CcSEcCtD
Tranylcypromine—Anorexia—Dexamethasone—psoriatic arthritis	0.000443	0.00332	CcSEcCtD
Tranylcypromine—Anorexia—Betamethasone—psoriatic arthritis	0.000443	0.00332	CcSEcCtD
Tranylcypromine—Urticaria—Prednisolone—psoriatic arthritis	0.000443	0.00331	CcSEcCtD
Tranylcypromine—Pain—Triamcinolone—psoriatic arthritis	0.000438	0.00328	CcSEcCtD
Tranylcypromine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000436	0.00326	CcSEcCtD
Tranylcypromine—Hypotension—Dexamethasone—psoriatic arthritis	0.000435	0.00325	CcSEcCtD
Tranylcypromine—Hypotension—Betamethasone—psoriatic arthritis	0.000435	0.00325	CcSEcCtD
Tranylcypromine—Hypertension—Prednisone—psoriatic arthritis	0.000429	0.00321	CcSEcCtD
Tranylcypromine—Chills—Methotrexate—psoriatic arthritis	0.000428	0.0032	CcSEcCtD
Tranylcypromine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000422	0.00316	CcSEcCtD
Tranylcypromine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000422	0.00315	CcSEcCtD
Tranylcypromine—Anxiety—Prednisone—psoriatic arthritis	0.000421	0.00315	CcSEcCtD
Tranylcypromine—Alopecia—Methotrexate—psoriatic arthritis	0.000421	0.00315	CcSEcCtD
Tranylcypromine—Insomnia—Dexamethasone—psoriatic arthritis	0.000421	0.00315	CcSEcCtD
Tranylcypromine—Insomnia—Betamethasone—psoriatic arthritis	0.000421	0.00315	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000418	0.00313	CcSEcCtD
Tranylcypromine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000418	0.00313	CcSEcCtD
Tranylcypromine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000418	0.00313	CcSEcCtD
Tranylcypromine—Urticaria—Triamcinolone—psoriatic arthritis	0.000407	0.00305	CcSEcCtD
Tranylcypromine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000406	0.00304	CcSEcCtD
Tranylcypromine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000405	0.00303	CcSEcCtD
Tranylcypromine—Oedema—Prednisone—psoriatic arthritis	0.000405	0.00303	CcSEcCtD
Tranylcypromine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000404	0.00303	CcSEcCtD
Tranylcypromine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000404	0.00303	CcSEcCtD
Tranylcypromine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000404	0.00303	CcSEcCtD
Tranylcypromine—Shock—Prednisone—psoriatic arthritis	0.000399	0.00298	CcSEcCtD
Tranylcypromine—Pain—Betamethasone—psoriatic arthritis	0.000398	0.00298	CcSEcCtD
Tranylcypromine—Pain—Dexamethasone—psoriatic arthritis	0.000398	0.00298	CcSEcCtD
Tranylcypromine—Tachycardia—Prednisone—psoriatic arthritis	0.000395	0.00296	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000392	0.00293	CcSEcCtD
Tranylcypromine—Vision blurred—Methotrexate—psoriatic arthritis	0.000391	0.00293	CcSEcCtD
Tranylcypromine—Anorexia—Prednisone—psoriatic arthritis	0.000386	0.00289	CcSEcCtD
Tranylcypromine—Anaemia—Methotrexate—psoriatic arthritis	0.000383	0.00287	CcSEcCtD
Tranylcypromine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000383	0.00287	CcSEcCtD
Tranylcypromine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000383	0.00287	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00038	0.00285	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00038	0.00285	CcSEcCtD
Tranylcypromine—Leukopenia—Methotrexate—psoriatic arthritis	0.000371	0.00278	CcSEcCtD
Tranylcypromine—Urticaria—Dexamethasone—psoriatic arthritis	0.00037	0.00277	CcSEcCtD
Tranylcypromine—Urticaria—Betamethasone—psoriatic arthritis	0.00037	0.00277	CcSEcCtD
Tranylcypromine—Dizziness—Prednisolone—psoriatic arthritis	0.000369	0.00276	CcSEcCtD
Tranylcypromine—Asthenia—Triamcinolone—psoriatic arthritis	0.000368	0.00275	CcSEcCtD
Tranylcypromine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000368	0.00275	CcSEcCtD
Tranylcypromine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000368	0.00275	CcSEcCtD
Tranylcypromine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000368	0.00275	CcSEcCtD
Tranylcypromine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000368	0.00275	CcSEcCtD
Tranylcypromine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000367	0.00275	CcSEcCtD
Tranylcypromine—Insomnia—Prednisone—psoriatic arthritis	0.000366	0.00274	CcSEcCtD
Tranylcypromine—Paraesthesia—Prednisone—psoriatic arthritis	0.000364	0.00272	CcSEcCtD
Tranylcypromine—Decreased appetite—Prednisone—psoriatic arthritis	0.000352	0.00264	CcSEcCtD
Tranylcypromine—Rash—Prednisolone—psoriatic arthritis	0.000352	0.00263	CcSEcCtD
Tranylcypromine—Dermatitis—Prednisolone—psoriatic arthritis	0.000351	0.00263	CcSEcCtD
Tranylcypromine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00035	0.00262	CcSEcCtD
Tranylcypromine—Headache—Prednisolone—psoriatic arthritis	0.000349	0.00261	CcSEcCtD
Tranylcypromine—Constipation—Prednisone—psoriatic arthritis	0.000346	0.00259	CcSEcCtD
Tranylcypromine—Confusional state—Methotrexate—psoriatic arthritis	0.000341	0.00255	CcSEcCtD
Tranylcypromine—Dizziness—Triamcinolone—psoriatic arthritis	0.000339	0.00254	CcSEcCtD
Tranylcypromine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000338	0.00253	CcSEcCtD
Tranylcypromine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000334	0.0025	CcSEcCtD
Tranylcypromine—Asthenia—Dexamethasone—psoriatic arthritis	0.000334	0.0025	CcSEcCtD
Tranylcypromine—Asthenia—Betamethasone—psoriatic arthritis	0.000334	0.0025	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000331	0.00248	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000331	0.00248	CcSEcCtD
Tranylcypromine—Nausea—Prednisolone—psoriatic arthritis	0.000331	0.00248	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000327	0.00245	CcSEcCtD
Tranylcypromine—Vomiting—Triamcinolone—psoriatic arthritis	0.000326	0.00244	CcSEcCtD
Tranylcypromine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000325	0.00243	CcSEcCtD
Tranylcypromine—Rash—Triamcinolone—psoriatic arthritis	0.000323	0.00242	CcSEcCtD
Tranylcypromine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000323	0.00242	CcSEcCtD
Tranylcypromine—Anorexia—Methotrexate—psoriatic arthritis	0.000323	0.00242	CcSEcCtD
Tranylcypromine—Rash—Methylprednisolone—psoriatic arthritis	0.000323	0.00241	CcSEcCtD
Tranylcypromine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000322	0.00241	CcSEcCtD
Tranylcypromine—Urticaria—Prednisone—psoriatic arthritis	0.000322	0.00241	CcSEcCtD
Tranylcypromine—Headache—Triamcinolone—psoriatic arthritis	0.000321	0.0024	CcSEcCtD
Tranylcypromine—Headache—Methylprednisolone—psoriatic arthritis	0.00032	0.0024	CcSEcCtD
Tranylcypromine—Abdominal pain—Prednisone—psoriatic arthritis	0.00032	0.0024	CcSEcCtD
Tranylcypromine—Body temperature increased—Prednisone—psoriatic arthritis	0.00032	0.0024	CcSEcCtD
Tranylcypromine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000318	0.00238	CcSEcCtD
Tranylcypromine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000318	0.00238	CcSEcCtD
Tranylcypromine—Hypotension—Methotrexate—psoriatic arthritis	0.000316	0.00237	CcSEcCtD
Tranylcypromine—Dizziness—Dexamethasone—psoriatic arthritis	0.000308	0.0023	CcSEcCtD
Tranylcypromine—Dizziness—Betamethasone—psoriatic arthritis	0.000308	0.0023	CcSEcCtD
Tranylcypromine—Insomnia—Methotrexate—psoriatic arthritis	0.000306	0.00229	CcSEcCtD
Tranylcypromine—Nausea—Triamcinolone—psoriatic arthritis	0.000305	0.00228	CcSEcCtD
Tranylcypromine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000304	0.00228	CcSEcCtD
Tranylcypromine—Nausea—Methylprednisolone—psoriatic arthritis	0.000304	0.00227	CcSEcCtD
Tranylcypromine—Somnolence—Methotrexate—psoriatic arthritis	0.000301	0.00225	CcSEcCtD
Tranylcypromine—Vomiting—Dexamethasone—psoriatic arthritis	0.000296	0.00221	CcSEcCtD
Tranylcypromine—Vomiting—Betamethasone—psoriatic arthritis	0.000296	0.00221	CcSEcCtD
Tranylcypromine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000294	0.0022	CcSEcCtD
Tranylcypromine—Rash—Dexamethasone—psoriatic arthritis	0.000293	0.00219	CcSEcCtD
Tranylcypromine—Rash—Betamethasone—psoriatic arthritis	0.000293	0.00219	CcSEcCtD
Tranylcypromine—Dermatitis—Betamethasone—psoriatic arthritis	0.000293	0.00219	CcSEcCtD
Tranylcypromine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000293	0.00219	CcSEcCtD
Tranylcypromine—Headache—Dexamethasone—psoriatic arthritis	0.000291	0.00218	CcSEcCtD
Tranylcypromine—Headache—Betamethasone—psoriatic arthritis	0.000291	0.00218	CcSEcCtD
Tranylcypromine—Asthenia—Prednisone—psoriatic arthritis	0.000291	0.00218	CcSEcCtD
Tranylcypromine—Pain—Methotrexate—psoriatic arthritis	0.00029	0.00217	CcSEcCtD
Tranylcypromine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000279	0.00209	CcSEcCtD
Tranylcypromine—Diarrhoea—Prednisone—psoriatic arthritis	0.000277	0.00207	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000277	0.00207	CcSEcCtD
Tranylcypromine—Nausea—Betamethasone—psoriatic arthritis	0.000276	0.00207	CcSEcCtD
Tranylcypromine—Nausea—Dexamethasone—psoriatic arthritis	0.000276	0.00207	CcSEcCtD
Tranylcypromine—Urticaria—Methotrexate—psoriatic arthritis	0.000269	0.00201	CcSEcCtD
Tranylcypromine—Dizziness—Prednisone—psoriatic arthritis	0.000268	0.002	CcSEcCtD
Tranylcypromine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000268	0.002	CcSEcCtD
Tranylcypromine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000268	0.002	CcSEcCtD
Tranylcypromine—Vomiting—Prednisone—psoriatic arthritis	0.000258	0.00193	CcSEcCtD
Tranylcypromine—Rash—Prednisone—psoriatic arthritis	0.000255	0.00191	CcSEcCtD
Tranylcypromine—Dermatitis—Prednisone—psoriatic arthritis	0.000255	0.00191	CcSEcCtD
Tranylcypromine—Headache—Prednisone—psoriatic arthritis	0.000254	0.0019	CcSEcCtD
Tranylcypromine—Asthenia—Methotrexate—psoriatic arthritis	0.000243	0.00182	CcSEcCtD
Tranylcypromine—Nausea—Prednisone—psoriatic arthritis	0.000241	0.0018	CcSEcCtD
Tranylcypromine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000232	0.00173	CcSEcCtD
Tranylcypromine—Dizziness—Methotrexate—psoriatic arthritis	0.000224	0.00168	CcSEcCtD
Tranylcypromine—Vomiting—Methotrexate—psoriatic arthritis	0.000215	0.00161	CcSEcCtD
Tranylcypromine—Rash—Methotrexate—psoriatic arthritis	0.000213	0.0016	CcSEcCtD
Tranylcypromine—Dermatitis—Methotrexate—psoriatic arthritis	0.000213	0.0016	CcSEcCtD
Tranylcypromine—Headache—Methotrexate—psoriatic arthritis	0.000212	0.00159	CcSEcCtD
Tranylcypromine—Nausea—Methotrexate—psoriatic arthritis	0.000201	0.0015	CcSEcCtD
